APDN - 1.39 Pre-market now at 1.57/1.66 Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines https://stockcharts.com/c-sc/sc?s=APDN&p=D&b=5&g=0&i=t49436718582&r=1537528917355